Techmash, a concern of Rostec Corporation, is building the first Russian complex of perfusion modules and devices for mobile systems of artificial blood circulation. The new product will allow resuscitation of patients with sudden cardiac arrest, and extend the life of donor organs in transplantology.
The manufacturing of prototypes and pre-clinical trials of new medical devices are scheduled for 2018. The industrial manufacturing of the complex is planned to start in 2020.
R&D are conducted by Techmash, a subsidiary of Rostec Corporation, in the NPO Splav together with the Russian State Scientific Center for Robotics and Technical Cybernetics in Saint-Petersburg. The First I.P. Pavlov State Medical University of St. Petersburg is acting as the advisor for the project.
“Today, one of the key challenges for the medicine is the period for transportation and storage of transplants in a form that is suitable for transplantation. These R&D will help to substantially increase the time for the functional activity of donor organs and, therefore, improve the chances of patients whose health depends on the results of transplantation,” said Vladimir Lepin, the General Director of SPC Techmash JSC.
The new medical devices will allow to restore the viability of donor organs by using the pulsating flow of oxygen-rich perfusate based on blood.